UPCOMING SESSIONS in ET
Wed, Apr 8, 2026
10:00 – 11:00 PM UTC
CAR-T Therapy for AL Amyloidosis: What’s New, What’s Real, and What’s Next Heather Landau Click To Register
UPCOMING SESSIONS in ET
Wed, Apr 8, 2026 · 10:00 – 11:00 PM UTC
CAR-T Therapy for AL Amyloidosis: What’s New, What’s Real, and What’s Next
Heather Landau
Click To Register
View all sessions

RNAi Therapeutics Market Growth 2024-2025

Published: Mar 20, 2025
Category
Business
Source
https://www.openpr.com/news/3926717/rnai-therapeutics-market-growth-2024-2025-alnylam-s

Advancements in RNAi Therapeutics | 2024-2025 Update for Investors in Hospitals and Healthcare

RNA interference (RNAi) therapeutics have garnered significant attention due to their innovative approach in treating a range of diseases. As of 2025, this sector is evolving rapidly, with numerous advancements that have the potential to reshape the landscape of healthcare.

News Url
RNAi Therapeutics Market Growth 2024-2025

Tags

Alternative Title
RNAi Therapeutics Market Growth 2024-2025 | Alnylam's Vutrisiran, Arrowhead's Plozasiran, Roche's Strategic Deals, and Investment Trends in Hospitals & Healthcare